trending Market Intelligence /marketintelligence/en/news-insights/trending/rz4awbgtq1sdqkv1vtytja2 content esgSubNav
In This List

OWC Pharmaceutical appoints chief scientific officer

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


OWC Pharmaceutical appoints chief scientific officer

OWC Pharmaceutical Research Corp. appointed Oron Zeevi as chief scientific officer.

Previously, Zeevi served as chief scientific officer at NeuroDerm Ltd., which was bought by Mitsubishi Tanabe Pharma Corp. for $1.1 billion in 2017.